These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2543894)

  • 21. Blood coagulation in postmenopausal women given estrogen treatment: comparison of transdermal and oral administration.
    Alkjaersig N; Fletcher AP; de Ziegler D; Steingold KA; Meldrum DR; Judd HL
    J Lab Clin Med; 1988 Feb; 111(2):224-8. PubMed ID: 2448408
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of long-term treatment with 8-prenylnaringenin and oral estradiol on the GH-IGF-1 axis and lipid metabolism in rats.
    Böttner M; Christoffel J; Wuttke W
    J Endocrinol; 2008 Aug; 198(2):395-401. PubMed ID: 18499805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Estrogen replacement in postmenopause, blood coagulation and fibrinolysis: comparison of a new kind of transdermal estradiol treatment with oral therapy with conjugated estrogens].
    Winkler UH; Krämer R; Kwee B; Schindler AE
    Zentralbl Gynakol; 1995; 117(10):540-8. PubMed ID: 7491837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
    Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hormone therapy in women in the menopause transition. Randomised, double-blind, placebo-controlled trial of effects on body weight, blood pressure, lipoprotein levels, antithrombin III activity, and the endometrium.
    Khoo SK; Coglan MJ; Wright GR; DeVoss KN; Battistutta D
    Med J Aust; 1998 Mar; 168(5):216-20. PubMed ID: 9539899
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels.
    Pluchino N; Genazzani AD; Bernardi F; Casarosa E; Pieri M; Palumbo M; Picciarelli G; Gabbanini M; Luisi M; Genazzani AR
    Gynecol Endocrinol; 2005 Mar; 20(3):144-9. PubMed ID: 16019353
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quality of life assessment in a chemoprevention trial: fenretinide and oral or transdermal HRT.
    Serrano D; Mariani L; Mora S; Guerrieri-Gonzaga A; Cazzaniga M; Daldoss C; Ramazzotto F; Feroce I; Decensi A; Bonanni B
    Maturitas; 2006 Aug; 55(1):69-75. PubMed ID: 16500052
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pulsed estrogen therapy: from cellular mode of action to tissue effects.
    Al-Azzawi F
    Climacteric; 2002 Jun; 5 Suppl 2():27-31. PubMed ID: 12482108
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effects of tamoxifen and estrogen replacement therapy on lipid metabolism and some other cardiovascular risk factors. A prospective study in hysterectomised women].
    Imperato F; Marziani R; Perniola G; Ebano V; Fruscella M; Mossa B
    Minerva Ginecol; 2003 Feb; 55(1):87-93. PubMed ID: 12598849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hormone replacement therapy in menopausal women: Past problems and future possibilities.
    Schmidt JW; Wollner D; Curcio J; Riedlinger J; Kim LS
    Gynecol Endocrinol; 2006 Oct; 22(10):564-77. PubMed ID: 17135036
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kinetics and pharmacology of estrogens in pre- and postmenopausal women.
    Anderson F
    Int J Fertil Menopausal Stud; 1993; 38 Suppl 1():55-64. PubMed ID: 8499960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of premarin, conjugated estrogens-equine to control. Functional uterine bleeding and the urinary estrogen metabolism after administration.
    Hamada H
    Bull Osaka Med Sch; 1971 Oct; 17(2):130-42. PubMed ID: 4347399
    [No Abstract]   [Full Text] [Related]  

  • 33. [The effects of hormone replacement therapy (HRT) on lipid metabolism in the menopause].
    Camilli A; Di Benedetto L; Camilli FM; Ermini M
    Minerva Ginecol; 1997 May; 49(5):199-202. PubMed ID: 9304079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral but not transdermal estrogen replacement therapy changes the composition of plasma lipoproteins.
    Vrablik M; Fait T; Kovar J; Poledne R; Ceska R
    Metabolism; 2008 Aug; 57(8):1088-92. PubMed ID: 18640386
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hormone substitution therapy. Side-effects and compliance of various therapeutic regimens].
    Perrone G; Barillaro F; Bazzoffi R; Capri O; Critelli C; Galoppi P; Grande S; Santoro G
    Minerva Ginecol; 1999 Mar; 51(3):53-8. PubMed ID: 10352534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of continuation of postmenopausal hormone replacement therapy: transdermal versus oral estrogen.
    Ettinger B; Pressman A; Bradley C
    Menopause; 1998; 5(3):152-6. PubMed ID: 9774760
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term effects of oral and transdermal hormone replacement therapies on serum lipid and lipoprotein concentrations.
    Whitcroft SI; Crook D; Marsh MS; Ellerington MC; Whitehead MI; Stevenson JC
    Obstet Gynecol; 1994 Aug; 84(2):222-6. PubMed ID: 8041534
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of percutaneous estradiol and conjugated estrogens on the level of plasma proteins and triglycerides in postmenopausal women.
    Elkik F; Gompel A; Mercier-Bodard C; Kuttenn F; Guyenne PN; Corvol P; Mauvais-Jarvis P
    Am J Obstet Gynecol; 1982 Aug; 143(8):888-92. PubMed ID: 6285744
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The fate of a large bolus of exogenous estrogen administered to postmenopausal women.
    Greenblatt RB; Natrajan PK; Aksu MF; Tzingounis VA
    Maturitas; 1980 Jan; 2(1):29-35. PubMed ID: 6250009
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comparison of the osteoprotective effects of orally administered equine conjugated estrogens and percutaneous 17 beta-estradiol].
    Reginster JY; Sarlet N; Deroisy R; Denis D; Lecart MP; Franchimont P
    Rev Med Liege; 1989 Jan; 44(2):55-60. PubMed ID: 2538905
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.